400 likes | 666 Views
Natalizumab for the Treatment of Crohn's Disease. Mechanism of action of natalizumabTreatment objectives for Crohn's disease, and the clinical trial tools used to evaluate themEfficacy of natalizumab in the Phase III clinical development program Induction of response (CD301, CD307) Maintenance o
E N D
1. Efficacy of Natalizumab in Crohn’s Disease Stephen Jones, MBBS
Director, Clinical Development
2. Natalizumab for the Treatment of Crohn’s Disease Mechanism of action of natalizumab
Treatment objectives for Crohn’s disease, and the clinical trial tools used to evaluate them
Efficacy of natalizumab in the Phase III clinical development program
Induction of response (CD301, CD307)
Maintenance of response (CD303)
Summary of Efficacy
3. Integrins Mediate Leukocyte Adhesion During Inflammation